| |
| |
|
| Insider
Information: |
Vittiglio Joseph |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
92,584 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$287,881 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,584 |
|
|
| Total
Value |
$287,881 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aveo Pharmaceuticals Inc |
AVEO |
SVP, General Counsel |
2015-01-07 |
16,437 |
|
0 |
Premium* |
|
|
AMAG Pharmaceuticals Inc |
AMAG |
Chief Business Officer... |
2020-11-16 |
0 |
2015-08-24 |
0 |
Premium* |
|
|
Finch Therapeutics Group, Inc. |
FNCH |
Chief Business & Legal... |
2022-10-21 |
31,364 |
2022-06-13 |
0 |
Premium* |
|
|
Bluebird Bio, Inc. |
BLUE |
|
2024-02-05 |
44,783 |
2023-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BLUE |
Bluebird Bio, Inc. |
Chief Business & Legal Officer |
• – – |
2024-02-05 |
4 |
S |
$0.90 |
$4,708 |
D/D |
(5,217) |
44,783 |
0 |
% |
|
| BLUE |
Bluebird Bio, Inc. |
Chief Business & Legal Officer |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| FNCH |
Finch Therapeutics Group,... |
Chief Business & Legal Officer |
• – – |
2022-10-21 |
4 |
S |
$1.39 |
$5,054 |
D/D |
(3,636) |
31,364 |
0 |
- |
|
| FNCH |
Finch Therapeutics Group,... |
Chief Business & Legal Officer |
• – – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer, GC |
• – – |
2020-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,244) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CBO, General Counsel |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
92,244 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CBO, General Counsel |
• – – |
2020-03-02 |
4 |
D |
$7.75 |
$8,820 |
D/D |
(1,138) |
67,244 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CBO, General Counsel |
• – – |
2020-02-25 |
4 |
D |
$8.84 |
$19,501 |
D/D |
(2,206) |
75,882 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
CBO, General Counsel |
• – – |
2020-02-23 |
4 |
D |
$9.50 |
$8,237 |
D/D |
(867) |
78,088 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2019-03-07 |
4 |
AS |
$14.01 |
$19,964 |
D/D |
(1,425) |
78,955 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2019-03-02 |
4 |
D |
$14.76 |
$16,915 |
D/D |
(1,146) |
80,380 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2019-03-01 |
4 |
D |
$14.76 |
$14,553 |
D/D |
(986) |
81,526 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
82,512 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2019-02-23 |
4 |
D |
$15.51 |
$13,478 |
D/D |
(869) |
50,512 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2018-08-24 |
4 |
D |
$24.60 |
$36,236 |
D/D |
(1,473) |
51,381 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2018-03-06 |
4 |
AS |
$20.80 |
$16,016 |
D/D |
(770) |
52,854 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2018-03-02 |
4 |
D |
$21.00 |
$21,231 |
D/D |
(1,011) |
53,624 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
54,635 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
EVP, General Counsel |
• – – |
2018-02-23 |
4 |
D |
$19.65 |
$17,076 |
D/D |
(869) |
32,635 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2017-08-29 |
4 |
AS |
$16.75 |
$20,938 |
D/D |
(1,250) |
33,504 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2017-08-24 |
4 |
D |
$17.50 |
$28,578 |
D/D |
(1,633) |
34,754 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2017-05-08 |
4 |
D |
$18.55 |
$18,179 |
D/D |
(980) |
36,387 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
37,367 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2016-08-24 |
4 |
D |
$24.85 |
$40,580 |
D/D |
(1,633) |
22,367 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
SVP, General Counsel |
• – – |
2016-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
24,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
